Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 129Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Titan Pharmaceutical Co. , Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Titan Pharmaceutical Co. , Ltd.

Country
Cosmoprof India
Not Confirmed
arrow

Titan Pharmaceutical Co. , Ltd.

Country
arrow
Cosmoprof India
Not Confirmed

Cefuroxime Axetil

Registration Number : 307MF10120

Registrant's Address : Lantang Town, Zijin County, Heyuan City, Guangdong Province, China

Initial Date of Registration : 2025-10-03

Latest Date of Registration : 2025-10-03

blank

Looking for 64544-07-6 / Cefuroxime Axetil API manufacturers, exporters & distributors?

Cefuroxime Axetil manufacturers, exporters & distributors 1

64

PharmaCompass offers a list of Cefuroxime Axetil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefuroxime Axetil manufacturer or Cefuroxime Axetil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefuroxime Axetil manufacturer or Cefuroxime Axetil supplier.

PharmaCompass also assists you with knowing the Cefuroxime Axetil API Price utilized in the formulation of products. Cefuroxime Axetil API Price is not always fixed or binding as the Cefuroxime Axetil Price is obtained through a variety of data sources. The Cefuroxime Axetil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cefuroxime Axetil

Synonyms

97232-96-7, Cefuroxime axetil, (e)-, 64544-07-6, (+/-)-cefuroxime axetil, (e)-, Xsl6i3sb26, Ceftin

Cas Number

64544-07-6

Unique Ingredient Identifier (UNII)

XSL6I3SB26

About Cefuroxime Axetil

Cefuroxime Axetil is a second generation semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefuroxime's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefuroxime inhibits bacterial septum and cell wall synthesis formation.

Cefuroxime Manufacturers

A Cefuroxime manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefuroxime, including repackagers and relabelers. The FDA regulates Cefuroxime manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefuroxime API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cefuroxime manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cefuroxime Suppliers

A Cefuroxime supplier is an individual or a company that provides Cefuroxime active pharmaceutical ingredient (API) or Cefuroxime finished formulations upon request. The Cefuroxime suppliers may include Cefuroxime API manufacturers, exporters, distributors and traders.

click here to find a list of Cefuroxime suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cefuroxime JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Cefuroxime Drug Master File in Japan (Cefuroxime JDMF) empowers Cefuroxime API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Cefuroxime JDMF during the approval evaluation for pharmaceutical products. At the time of Cefuroxime JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Cefuroxime suppliers with JDMF on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.